News Overview

SARS-CoV-2 has made it very clear to us: As we age, the defense by our immune system against viruses can be very poor sometimes. Unfortunately, also vaccinations show often only weak effects in elderly individuals and infections can progress more severely than in younger people. Why is that? In [...]

“I am very pleased that I can support RESIST now to achieve its goals”, says Chris Lauber, who is since mid-June professor for Computational Virology at MHH. Professor Lauber works at the Institute for Experimental Virology at TWINCORE and is the third professor financed by RESIST. Professor Lauber and [...]

Numerous RESIST scientists in the various institutions have expanded their work and are now also focusing on SARS-CoV-2: Professor Dr. Luka Čičin-Šain at the HZI is developing new technologies for improved serological virus diagnostics, for vaccine development and for identification of antiviral molecules against SARS-CoV-2. His team also works [...]

People who have successfully mastered an infection with SARS-CoV-2 have various protective antibodies in their blood. Some of these substances are particularly effective. Detecting these highly potent antibodies, producing them genetically in the laboratory and then using them to protect against infection and to treat the disease – this [...]

In his search for a suitable vaccine against the coronavirus SARS-CoV-2, Professor Förster relies on old friends. In cooperation with the Ludwig-Maximilians-Universität München (LMU), the co-speaker of RESIST is testing a promising vaccine based on a smallpox virus. The Modified Vaccinia Virus Ankara (MVA) has been used as a [...]

Sarina Ravens and Jens Bosse received their certificates of professorship appointment on 30th April 2020 at the MHH Presidium. Since May, they have obtained the first professorships financed by the Cluster of Excellence RESIST. Professor Dr. Sarina Ravens is now Professor of Systemic Human Immunology. She has already been [...]

RESIST-Scientist Professor Pietschmann leads the German part of an international consortium of scientists. This research network is searching for substances that act against SARS-CoV-2 in the world's largest substance repurposing bank "ReFrame". Innovations based on proven active ingredients, new indications for established drugs – the principle of repurposing has [...]

Professor Schulz answered numerous questions about the novel coronavirus, together with MHH colleagues. The interview can be found here (on the homepage of the Hanover Medical School). More information about our research

Dr. Gisa Gerold, Researcher of the TWINCORE – Centre for Experimental and Clinical Infection Research and visiting professor at Umea University in Sweden, is associated with RESIST: Her PhD student Lisa Laßwitz will be funded by RESIST for six months. Dr. Gerold's team investigates, within the framework of RESIST, [...]

Five researchers of our Cluster of Excellence RESIST have been elected to the Review Boards of the German Research Foundation (DFG): Professor Dr. Gesine Hansen has been elected to the Review Board "Child and Youth Medicine", Professor Dr. Beate Sodeik and Professor Dr. Thomas Pietschmann to the Review Board [...]

RESIST research is the current cover story of MHHinfo. It provides an overview, illustrates research on specific diseases using patient examples, explains the cohorts for conducting clinical studies and reports on initial RESIST publications. In this way, readers can find out what the RESIST team uses all its knowledge [...]

How many people in Germany have a congenital immunodeficiency that makes them particularly susceptible to infectious diseases? And which of the approximately 200 known forms of immunodeficiencies do they have? In order to be able to answer such questions, data on patients have been collected since 2009 in the [...]

The immune system protects against the formation of biofilms. That was previously believed. In contrast, however, now RESIST researchers led by Professor Dr. Reinhold Förster have discovered that the immune system enhances the formation of biofilms with the help of a new developed mouse model for their research. Biofilms [...]

In order to better understand the factors underlying individual susceptibility to infectious diseases, numerous experts met from 30 September to 1 October 2019 for the first "Hannover Symposium on Infection Susceptibility". The photo shows the participants in front of and on the stairs of "Schloss Herrenhausen". You can find [...]